<?xml version="1.0" encoding="utf-8"?>
<?xml-stylesheet type="text/xsl" href="http://medicalxpress.com/tmpl/default/css/default/feedRSS.xsl"?>
<rss version="2.0" 
	xmlns:media="http://search.yahoo.com/mrss/">
<channel>
<title>Medical Xpress: PHYSorg news tagged with: fda</title>
<link>http://medicalxpress.com/</link>
<language>en-us</language> 
<description>Medical Xpress internet news portal provides the latest news on Health and Medicine.</description>

 <item>
     <title>Addiction researcher optimistic about new, highly visual labels that show ill effects of smoking</title>
   	 <description>By presenting the concrete reality of what will happen as a result of smoking, the new anti-smoking warnings that will show up on packs of cigarettes next year have a good chance of discouraging smoking, said Warren Bickel, professor at the Virginia Tech Carilion Research Institute.</description>
	  <link>http://medicalxpress.com/news/2011-06-addiction-optimistic-highly-visual-ill.html</link>
	 <category>Health</category>
	 <pubDate>Mon, 27 Jun 2011 08:21:32 EST</pubDate>
	 <guid isPermaLink="false">news228381680</guid>
	 
</item>
<item>
     <title>Where there's smoke, there's ire</title>
   	 <description>Speakers at an all-day conference at the Harvard School of Public Health (HSPH) hailed a two-year-old federal law giving the U.S. Food and Drug Administration (FDA) power to regulate cigarettes as a key opportunity to further reduce smoking&amp;#146;s impact on people&amp;#146;s health.</description>
	  <link>http://medicalxpress.com/news/2011-06-ire.html</link>
	 <category>Health</category>
	 <pubDate>Mon, 27 Jun 2011 07:40:15 EST</pubDate>
	 <guid isPermaLink="false">news228379071</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2011/wheretheress.jpg" width="90" height="90" />
</item>
<item>
     <title>FDA approval for Siemens PET Scan - MRI combo</title>
   	 <description>(Medical Xpress) -- The Siemens Biograph mMR system, offering both a PET scan and an MRI that work simultaneously, has been given approval by the FDA. The idea behind this machine and the ability to run both tests at the same time is expected to save diagnostic time as well as reduce a patient&amp;#146;s exposure to radiation.</description>
	  <link>http://medicalxpress.com/news/2011-06-fda-siemens-pet-scan-.html</link>
	 <category>Cancer</category>
	 <pubDate>Mon, 13 Jun 2011 12:23:49 EST</pubDate>
	 <guid isPermaLink="false">news227186606</guid>
	 
</item>
<item>
     <title>FDA announces new limits on high-dose simvastatin (Zocor)</title>
   	 <description>The United States Food and Drug Administration (FDA) today announced new limitations to the use of high-dose simvastatin, due to the increased risk of muscle pain and weakness (myopathy) and in rare cases, kidney damage and failure.</description>
	  <link>http://medicalxpress.com/news/2011-06-fda-limits-high-dose-simvastatin-zocor.html</link>
	 <category>Cardiology</category>
	 <pubDate>Thu, 09 Jun 2011 11:42:39 EST</pubDate>
	 <guid isPermaLink="false">news226838536</guid>
	 
</item>
<item>
     <title>New device offers revolutionary treatment for difficult-to-Treat brain aneurysms</title>
   	 <description>Physicians at Rush University Medical Center are offering a new and effective treatment to patients suffering from complex brain aneurysms. The recently FDA-approved technology called the Pipeline Embolization Device (PED gives doctors the ability for the very first time to treat some of the most complex and dangerous brain aneurysms using minimally invasive techniques.  The treatment is focused on reconstruction or remodeling of the weak blood vessel harboring the brain aneurysm. </description>
	  <link>http://medicalxpress.com/news/2011-06-device-revolutionary-treatment-difficult-to-treat-brain.html</link>
	 <category>Other</category>
	 <pubDate>Wed, 08 Jun 2011 09:22:02 EST</pubDate>
	 <guid isPermaLink="false">news226743619</guid>
	 
</item>
<item>
     <title>Antifungal drug delays need for chemo in advanced prostate cancer</title>
   	 <description>The oral antifungal drug itraconazole, most commonly used to treat nail fungus, may keep prostate cancer from worsening and delay the need for chemotherapy in men with advanced disease.  Details of the finding, from a clinical trial led by Johns Hopkins experts, are scheduled for presentation on Saturday, June 4 at the 2011 American Society of Clinical Oncology (ASCO) annual meeting (abstract #4532).</description>
	  <link>http://medicalxpress.com/news/2011-06-antifungal-drug-chemo-advanced-prostate.html</link>
	 <category>Cancer</category>
	 <pubDate>Thu, 02 Jun 2011 13:16:37 EST</pubDate>
	 <guid isPermaLink="false">news226239375</guid>
	 
</item>
<item>
     <title>UCSF scientists play key role in success of Yervoy, a new cancer drug</title>
   	 <description>Yervoy is unlikely to win a contest for best named drug, but recent US Food and Drug Administration (FDA) approval for the new entrant in the battle against cancer marks the success of a novel treatment strategy, and is another indicator that immunotherapy has gone mainstream.</description>
	  <link>http://medicalxpress.com/news/2011-05-ucsf-scientists-key-role-success.html</link>
	 <category>Cancer</category>
	 <pubDate>Fri, 06 May 2011 09:52:04 EST</pubDate>
	 <guid isPermaLink="false">news223894307</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2011/t-cells.jpg" width="90" height="90" />
</item>
<item>
     <title>Hair loss robot gains FDA approval</title>
   	 <description>(Medical Xpress) -- Restoration Robotics Inc., a privately-held medical device company which is based in California, has received FDA approval for their ARTAS System. The ARTAS System, which is designed to harvest the hair follicles from the scalp of men who have been diagnosed with androgenetic alopecia, a condition that is more commonly known as male pattern hair loss, in men who also have black or brown straight hair, has received its 510K clearance from the Food &amp; Drug Administration.</description>
	  <link>http://medicalxpress.com/news/2011-04-hair-loss-robot-gains-fda.html</link>
	 <category>Medical research</category>
	 <pubDate>Tue, 26 Apr 2011 13:46:36 EST</pubDate>
	 <guid isPermaLink="false">news223044379</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2011/hairlossrobo.jpg" width="90" height="91" />
</item>
<item>
     <title>FDA approval of brain aneurysm device gives Jefferson neurosurgeons another life-saving tool</title>
   	 <description>The recent U.S. Food and Drug Administration (FDA) approval of a brain aneurysm device has opened the door for neurosurgeons at Jefferson Hospital for Neuroscience (JHN) to offer advanced treatment to patients suffering from large or giant aneurysms who otherwise have limited, effective options.</description>
	  <link>http://medicalxpress.com/news/2011-04-fda-brain-aneurysm-device-jefferson.html</link>
	 <category>Other</category>
	 <pubDate>Mon, 18 Apr 2011 16:13:41 EST</pubDate>
	 <guid isPermaLink="false">news222362008</guid>
	 
</item>
<item>
     <title>New drug may reduce seizures in epilepsy</title>
   	 <description>A new drug called perampanel appears to significantly reduce seizures in people with hard-to-control epilepsy, according to results of the first clinical trial to test the higher 12 mg dose of the drug.  The late-breaking research will be presented at the 63rd Annual Meeting of the American Academy of Neurology, April 9-16, 2011, in Honolulu.</description>
	  <link>http://medicalxpress.com/news/2011-04-drug-seizures-epilepsy.html</link>
	 <category>Neuroscience</category>
	 <pubDate>Wed, 13 Apr 2011 16:35:27 EST</pubDate>
	 <guid isPermaLink="false">news221931313</guid>
	 
</item>


</channel>
</rss>
